Health & Biotech
Dr Boreham’s Crucible: This hearing-aid stock is well tuned in to an evolving, competitive field
Health Check: After an ‘extraordinary’ year, analysts reckon Telix has a lot more tiger in the tank
Scott Power: ASX health stocks up in mixed earnings season, Mayne surges on $672 million US buyout
Wellnex directors commit to $1.5 million in entitlement offer ahead of London listing
Buddying up: How small ASX healthcare stocks are teaming with giants for growth
Optiscan unveils ‘digital pathology workhorse’ to speed up diagnostics
London calling: Wellnex Life secures $14.3 million for LSE listing
Health Check: It’s show-and-tell time for three of our home-grown heroes
Imricor’s second-generation Vision-MR Ablation Catheter earns CE mark
Imagion to start production of MagSense imaging agent for phase II breast cancer trial
Health Check: EBOS Group’s earnings surge – or plunge – but bottom line is, pharmacies are in rude health
Middle East healthcare expansion opens doors for ASX stocks
Biocurious: Cashed up and pursuing the ‘c’ word, Imugene is on the verge of transforming cancer immunotherapy
‘One straightforward request’: Neurizon buoyant on FDA clarity
Health Check: With its last patient treated, Opthea eyes pending results of do-or-die trial
Dr Boreham’s Crucible: What’s all the fuss about biotech behemoth CSL?
Health Check: Brokers slash Cochlear valuations as customers hold tight on product upgrades
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
